Felice Gragnano, Paolo Calabrò, Vincenzo De Sio, Massimo Imazio, Giuseppe Patti, Raffaele De Caterina, Pasquale Perrone Filardi, Sergio Leonardi
Inflammation plays an important role in cardiovascular disease. Growing evidence suggests a profound involvement of the inflammatory response in the development and progression of atherosclerosis and its complications. In patients with atherosclerotic cardiovascular disease (ASCVD), residual cardiovascular risk often remains high despite optimal medical therapy and the achievement of the therapeutic targets recommended by current guidelines. Among the multiple components of residual risk, residual inflammatory risk, assessed by plasma levels of high-sensitivity C-reactive protein, has shown a strong association with the incidence of cardiovascular events...
December 2022: Giornale Italiano di Cardiologia